300759 康龙化成
开盘竞价 11-19 09:30:00
资讯
新帖
简况
康龙化成获得发明专利授权：“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”
证券之星 · 11-16
康龙化成获得发明专利授权：“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”
康龙化成(03759)下跌5.05%，报14.3元/股
金融界 · 11-14
康龙化成(03759)下跌5.05%，报14.3元/股
香港政府引进新一批重点企业落户，以中国内地科技企业为主
路透中文 · 11-11
香港政府引进新一批重点企业落户，以中国内地科技企业为主
中原证券：给予康龙化成增持评级
证券之星 · 11-08
中原证券：给予康龙化成增持评级
《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善
路透中文 · 11-04
《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善
开源证券：给予康龙化成买入评级
证券之星 · 11-01
开源证券：给予康龙化成买入评级
大摩：重申康龙化成(03759)“增持”评级 目标价上调至24.2港元
智通财经 · 11-01
大摩：重申康龙化成(03759)“增持”评级 目标价上调至24.2港元
大摩：上调康龙化成目标价至24.2港元 第三季业绩显示公司正加快复苏
金融界 · 11-01
大摩：上调康龙化成目标价至24.2港元 第三季业绩显示公司正加快复苏
《大行》大摩升康龙化成(03759.HK)目标价至24.2元 加速复苏为稳健前景铺平道路
阿斯达克财经 · 11-01
《大行》大摩升康龙化成(03759.HK)目标价至24.2元 加速复苏为稳健前景铺平道路
【机构调研记录】汇添富基金调研康龙化成、传音控股等14只个股（附名单）
证券之星 · 11-01
【机构调研记录】汇添富基金调研康龙化成、传音控股等14只个股（附名单）
康龙化成：10月30日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与
证券之星 · 10-31
康龙化成：10月30日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与
【港股通】康龙化成(03759)跌超4% 里昂指其第三季业绩符预期 惟削目标价8.2%
金吾财讯 · 10-30
【港股通】康龙化成(03759)跌超4% 里昂指其第三季业绩符预期 惟削目标价8.2%
康龙化成(03759)股价下跌5.057%，现价港币$15.02
阿斯达克财经 · 10-30
康龙化成(03759)股价下跌5.057%，现价港币$15.02
康龙化成（300759）10月29日主力资金净卖出1.88亿元
证券之星 · 10-30
康龙化成（300759）10月29日主力资金净卖出1.88亿元
康龙化成(300759.SZ)发布前三季度业绩，净利润14.22亿元，增长24.82%
智通财经 · 10-30
康龙化成(300759.SZ)发布前三季度业绩，净利润14.22亿元，增长24.82%
康龙化成最新公告：第三季度净利润3.08亿元 同比下降12.62%
证券之星 · 10-29
康龙化成最新公告：第三季度净利润3.08亿元 同比下降12.62%
《业绩》康龙化成(03759.HK)首三季净利润按年升24.8%
阿斯达克财经 · 10-29
《业绩》康龙化成(03759.HK)首三季净利润按年升24.8%
康龙化成(03759)发布前三季度业绩 归母净利润14.22亿元 同比增加24.82%
智通财经 · 10-29
康龙化成(03759)发布前三季度业绩 归母净利润14.22亿元 同比增加24.82%
10月29日康龙化成跌5.39%，中欧医疗健康混合A基金重仓该股
证券之星 · 10-29
10月29日康龙化成跌5.39%，中欧医疗健康混合A基金重仓该股
增持药明康德、康龙化成，中欧基金葛兰：优质企业才能够真正走出产业调整周期
澎湃新闻 · 10-25
增持药明康德、康龙化成，中欧基金葛兰：优质企业才能够真正走出产业调整周期
暂无数据
公司概况
公司名称：
康龙化成(北京)新药技术股份有限公司
所属行业：
研究和试验发展
上市日期：
2019-01-28
主营业务：
康龙化成(北京)新药技术股份有限公司主营业务是从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要服务为实验室服务、CMC(小分子CDMO)服务、临床研究服务、大分子和细胞与基因治疗服务四大服务板块。
发行价格：
7.66
{"stockData":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":27.74,"timestamp":1731979272000,"preClose":27.48,"halted":0,"volume":0,"delay":0,"floatShares":1429000000,"shares":1787000000,"eps":1.054,"marketStatus":"开盘竞价","marketStatusCode":1,"change":0.26,"latestTime":"11-19 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":27.74,"askSize":127,"bidPrice":27.74,"bidSize":127,"shortable":0,"etf":0,"ttmEps":1.054,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"adjPreClose":27.48,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":30.23,"lowLimit":24.73,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1787394297,"pbRate":3.67,"roa":"--","roe":"10.9%","epsLYR":0.9033,"committee":-0.069597,"marketValue":49582000000,"floatMarketCap":39629000000,"peRate":26.318785,"changeRate":0.0095,"turnoverRate":0,"status":0},"requestUrl":"/m/hq/s/300759/tweets","defaultTab":"tweets","newsList":[{"id":"2483584125","title":"康龙化成获得发明专利授权：“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584125","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584125?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:36","pubTimestamp":1731699383,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示康龙化成新获得一项发明专利授权，专利名为“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”，专利申请号为CN202410268143.4，授权日为2024年11月12日。今年以来康龙化成新获得专利授权14个，较去年同期增加了7.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600007935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK1141","03759","BK1576","BK0216"],"gpt_icon":0},{"id":"2483810344","title":"康龙化成(03759)下跌5.05%，报14.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483810344","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483810344?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:54","pubTimestamp":1731567252,"startTime":"0","endTime":"0","summary":"11月14日，康龙化成(03759)盘中下跌5.05%，截至14:54，报14.3元/股，成交8305.82万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年三季报，康龙化成营业总收入88.17亿元、净利润14.22亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14145445284254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300759","BK0216","BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2482208421","title":"香港政府引进新一批重点企业落户，以中国内地科技企业为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2482208421","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482208421?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:38","pubTimestamp":1731317926,"startTime":"0","endTime":"0","summary":"政府表示，连同早前引进约50家重点企业，全部企业在未来数年将会在香港合共投资约420亿港元，创造超过17,000个职位；在投资香港的同时，也会积极带动其产业链上、中、下游的企业来到香港。除了引进重点企业，香港为引进资金和高净值人士的新资本投资者入境计划，当中规定注资的投资组合，将在2025年第一季启动对创新及科技企业投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4T3MI0N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09888","BK0188","LU0348825331.USD","LU0630378429.USD","LU0315179316.USD","HK0000320264.USD","LU0359201612.USD","89888","SGXZ81163826.USD","LU0051755006.USD","SG9999002828.SGD","LU0197773673.USD","LU0348735423.USD","BK0133","LU0359202008.SGD","LU0039217434.USD","LU1115378108.SGD","LU0762542818.HKD","SG9999002463.SGD","LU0456827905.SGD","LU0831093199.SGD","IE0034224299.USD","BK0126","LU0043850808.USD","LU0197773160.USD","002230","BK1095","LU0417516738.SGD","LU0417516902.SGD","300759","HK0000306685.HKD","BIDU","LU0163747925.USD","LU0762540952.USD","LU0405327148.USD","LU0640798160.USD","LU0708995583.HKD","LU0856984785.SGD","BK0183","LU0326950275.SGD","LU0320764599.SGD","LU0543330566.HKD","BK1587","BK1609","LU0229945570.USD","LU0588546209.SGD","BK0129","LU1048596156.SGD","LU1328615791.USD","BK1575"],"gpt_icon":1},{"id":"2481252126","title":"中原证券：给予康龙化成增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481252126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481252126?lang=zh_cn&edition=full","pubTime":"2024-11-08 18:01","pubTimestamp":1731060083,"startTime":"0","endTime":"0","summary":"中原证券股份有限公司李琳琳近期对康龙化成进行研究并发布了研究报告《季报点评：3Q业绩环比改善，CMC新签订单增速较快》，本报告对康龙化成给出增持评级，当前股价为30.55元。 预计公司2024-2026年每股收益分别为0.98元，1.10元和1.30元，对应11月7日收盘价，市盈率分别为31.58倍，28.17倍和23.77倍，给予公司“增持”的投资评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800031425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601375","300759","03759"],"gpt_icon":0},{"id":"2480275923","title":"《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2480275923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480275923?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:26","pubTimestamp":1730705198,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善* 为制药公司代工研发药物的中国康龙化成A股300759.SZ周一盘中一度升5.2%，报30.28元，终场收涨2.8%；其H股3759.HK亦最多上扬5%，报15.98港元。* 花旗在报告中表示，将康龙化成A股的目标价由25元上调至30元，H股的目标价由28港元上调至33港元。H股评级为“买入”，但由于估值原因，将A股评级降为“中性”。* 康龙化成H股今年迄今跌2.1%，同期恒生指数.HSI大幅上扬20.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nL4S3MB0DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","300759"],"gpt_icon":0},{"id":"2480887122","title":"开源证券：给予康龙化成买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887122?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:35","pubTimestamp":1730471741,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对康龙化成进行研究并发布了研究报告《公司信息更新报告：新签订单稳健增长，连续三个季度实现温和复苏》，本报告对康龙化成给出买入评级，当前股价为28.79元。最新盈利预测明细如下：该股最近90天内共有15家机构给出评级，买入评级11家，增持评级3家，中性评级1家；过去90天内机构目标均价为24.18。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100049334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","161027","03759"],"gpt_icon":0},{"id":"2480360046","title":"大摩：重申康龙化成(03759)“增持”评级 目标价上调至24.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480360046","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480360046?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:26","pubTimestamp":1730431584,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研究报告称，重申康龙化成“增持”评级，H股目标价由15.7港元上调至24.2港元。第三季经调整净利润同比跌13.2%至4.17亿元人民币，则符合该行预期。大摩预期康龙化成未来几个季度的盈利增长将转正，积压订单及收入增长持续改善可为明年的双位数增长铺路。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","03759"],"gpt_icon":0},{"id":"2480463260","title":"大摩：上调康龙化成目标价至24.2港元 第三季业绩显示公司正加快复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2480463260","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480463260?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:06","pubTimestamp":1730430406,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指，康龙化成第三季业绩显示公司正加快复苏，第三季收入录得32亿元，按年增长10%，较次季的按年增长1%显著改善，毛利率按年提升0.8个百分点，主要受惠于实验室及CMC ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241101/c663068886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300759"],"gpt_icon":0},{"id":"2480104840","title":"《大行》大摩升康龙化成(03759.HK)目标价至24.2元 加速复苏为稳健前景铺平道路","url":"https://stock-news.laohu8.com/highlight/detail?id=2480104840","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480104840?lang=zh_cn&edition=full","pubTime":"2024-11-01 10:14","pubTimestamp":1730427240,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指，康龙化成第三季业绩显示公司正加快复苏，第三季收入录得32亿元人民币，按年增长10%，较次季的按年增长1%显著改善，毛利率按年提升0.8个百分点，主要受惠于实验室及CMC服务的盈利能力改善。第三季经调整净利润按年跌13.2%至4.17亿元人民币，则符合该行预期。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210817120929882_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210817120929882_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1393273/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03759","300759"],"gpt_icon":0},{"id":"2480090658","title":"【机构调研记录】汇添富基金调研康龙化成、传音控股等14只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2480090658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480090658?lang=zh_cn&edition=full","pubTime":"2024-11-01 08:06","pubTimestamp":1730419563,"startTime":"0","endTime":"0","summary":"7）圆通速递 个股亮点：阿里巴巴集团就宣布联手云锋新创战略投资圆通速递,阿里创投、云锋新创分别持有11.08%和6.42%,位列第二和第三大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100009277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","688036","03759","LU2328871848.SGD","BK1576","LU1969619763.USD","300759","BK0216","SGXZ49509284.SGD","SGXZ81163826.USD","BK0214"],"gpt_icon":0},{"id":"2479776928","title":"康龙化成：10月30日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479776928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479776928?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:24","pubTimestamp":1730363086,"startTime":"0","endTime":"0","summary":"康龙化成2024年三季报显示，公司主营收入88.17亿元，同比上升3.0%；归母净利润14.22亿元，同比上升24.82%；扣非净利润7.83亿元，同比下降27.69%；其中2024年第三季度，公司单季度主营收入32.13亿元，同比上升10.02%；单季度归母净利润3.08亿元，同比下降12.62%；单季度扣非净利润3.17亿元，同比下降3.43%；负债率40.49%，投资收益6.16亿元，财务费用1.33亿元，毛利率33.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100031481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300759","03759","BK1141","BK1576"],"gpt_icon":0},{"id":"2479467392","title":"【港股通】康龙化成(03759)跌超4% 里昂指其第三季业绩符预期 惟削目标价8.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479467392","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479467392?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:56","pubTimestamp":1730267783,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康龙化成 股价震荡走低，截至发稿，报15.12港元，跌4.42%，成交额1.73亿港元。消息面上，中信里昂发研报指，康龙化成第三季收入以及经调整纯利均按季改善，收入从今年第二季度的同比增1%，改善至第三季度的同比增10%，经调整纯利从同比减29%改善至同比减13%，均符合市场预期。该公司预计2024年下半年收入将增长10%以上。该行上调对康龙化成2024-2026年纯利2-5%，反映2024年第三季业绩。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ODEyMDM1NzM2NTU5NjM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODEyMDM1NzM2NTU5NjM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946774","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300759","HSTECH","YANG","03759","HSCEI"],"gpt_icon":0},{"id":"2479243651","title":"康龙化成(03759)股价下跌5.057%，现价港币$15.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2479243651","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479243651?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:15","pubTimestamp":1730265300,"startTime":"0","endTime":"0","summary":"[下跌股]康龙化成(03759) 股价在下午01:15比前收市价下跌5.057%，现股价为港币$15.02。至目前为止，今日最高价为$16.36，而最低价为$15.02。总成交量为988.29万股，总成交金额为港币$1.539亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2410302473/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0216","BK1576","03759","300759","BK1141"],"gpt_icon":0},{"id":"2479769291","title":"康龙化成（300759）10月29日主力资金净卖出1.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479769291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479769291?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:22","pubTimestamp":1730251323,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月29日收盘，康龙化成报收于30.01元，下跌5.39%，换手率4.29%，成交量61.22万手，成交额18.93亿元。10月29日的资金流向数据方面，主力资金净流出1.88亿元，占总成交额9.92%，游资资金净流出2505.73万元，占总成交额1.32%，散户资金净流入2.13亿元，占总成交额11.24%。融券方面，融券卖出9700.0股，融券偿还7500.0股，融券余量3.44万股，融券余额103.08万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000010494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK1141","BK1576","300759","BK0216"],"gpt_icon":0},{"id":"2479858236","title":"康龙化成(300759.SZ)发布前三季度业绩，净利润14.22亿元，增长24.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479858236","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479858236?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:33","pubTimestamp":1730219584,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(300759.SZ)发布2024年三季度报告，该公司前三季度营业收入为88.17亿元，同比增长3.00%。归属于上市公司股东的净利润为14.22亿元，同比增长24.82%。归属于上市公司股东的扣除非经常性损益的净利润为7.83亿元，同比减少27.69%。基本每股收益为0.8028元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1203226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","03759"],"gpt_icon":0},{"id":"2479477172","title":"康龙化成最新公告：第三季度净利润3.08亿元 同比下降12.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479477172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479477172?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:01","pubTimestamp":1730199665,"startTime":"0","endTime":"0","summary":"康龙化成发布2024年第三季度报告，前三季度实现营业收入88.17亿元，同比增长3%；归属于上市公司股东的净利润14.22亿元，同比增长24.82%。其中，第三季度实现营业收入32.13亿元，同比增长10.02%；归属于上市公司股东的净利润3.08亿元，同比下降12.62%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900035109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","300759"],"gpt_icon":0},{"id":"2479047644","title":"《业绩》康龙化成(03759.HK)首三季净利润按年升24.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479047644","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479047644?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:54","pubTimestamp":1730195640,"startTime":"0","endTime":"0","summary":"康龙化成(03759.HK) 公布9月止首三季度业绩，按国际财务报告准则，实现营业收入88.17亿人民币(下同)，按年增加3%。净利润14.22亿元，增长24.82%，每股基本收益0.8028元。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-29 16:25。)过往派息公布日期派息事项派息内容2024/08/27中期业绩无派息2024/04/25第一季业绩无派息2024/03/27末期业绩普通股息：人民币 0.2 (相当于港元 0.2198899)2023/10/29第三季业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210817120929522_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210817120929522_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392067/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03759","300759"],"gpt_icon":0},{"id":"2479147565","title":"康龙化成(03759)发布前三季度业绩 归母净利润14.22亿元 同比增加24.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479147565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479147565?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:51","pubTimestamp":1730195511,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成 发布2024年第三季度报告，该集团期内取得营业收入88.17亿元，同比增加3%;归母净利润14.22亿元，同比增加24.82%;基本每股收益0.8028元。2024年前三季度，公司位于中国的、服务于全球客户的实验室和工厂，收入同比增长3.67%，占公司营业收入的87.22%;公司位于海外的实验室和工厂，收入同比下降1.34%，占营业收入的12.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","03759"],"gpt_icon":0},{"id":"2479429045","title":"10月29日康龙化成跌5.39%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479429045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479429045?lang=zh_cn&edition=full","pubTime":"2024-10-29 16:22","pubTimestamp":1730190137,"startTime":"0","endTime":"0","summary":"证券之星消息，10月29日康龙化成跌5.39%，收盘报30.01元，换手率4.29%，成交量61.22万手，成交额18.93亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共58家，其中持有数量最多的公募基金为中欧医疗健康混合A。中欧医疗健康混合A目前规模为184.44亿元，最新净值1.6975，较上一交易日上涨0.97%，近一年下跌13.22%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900027607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","03759","159760","BK1576","300759","BK0216"],"gpt_icon":0},{"id":"2478498522","title":"增持药明康德、康龙化成，中欧基金葛兰：优质企业才能够真正走出产业调整周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2478498522","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478498522?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:35","pubTimestamp":1729856100,"startTime":"0","endTime":"0","summary":"10月25日，中欧基金葛兰在管的3只公募基金披露2024年二季报，其持仓情况也随之浮出水面。另一方面，药明康德、康龙化成、泰格医药则获葛兰加仓，增持比例依次为9.83%、6.24%、3.27%。在宏观环境持续变化、行业内部不断调整的阶段中，葛兰仍旧认为只有具备核心产品竞争力、 高效经营管理能力的优质企业才能够真正走出产业调整周期，迎来可持续的长期发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025193616a1ea3206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025193616a1ea3206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU1997245177.USD","LU1997245094.SGD","02359","300759","LU0456842615.SGD","603259","BK0216","03759"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-01-28","address":"北京市大兴区北京经济技术开发区泰河路6号1幢八层","stockEarnings":[{"period":"1week","weight":-0.129},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.3774},{"period":"6month","weight":0.2576},{"period":"1year","weight":-0.1878},{"period":"ytd","weight":-0.0418}],"companyName":"康龙化成(北京)新药技术股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"178739万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 康龙化成(北京)新药技术股份有限公司主营业务是从药物发现到药物开发的全流程一体化药物研究、开发及生产服务。公司的主要服务为实验室服务、CMC(小分子CDMO)服务、临床研究服务、大分子和细胞与基因治疗服务四大服务板块。","serverTime":1731979302336,"listedPrice":7.66,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,300759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(300759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(300759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}